Although intensive insulin therapy for T1D to optimize glycemic control reduces the incidence of microvascular complications, there is concern over excessive weight gain during treatment8,9, which may compromise metabolic control and lead to cardiovascular diseases10,11. Here, INS is linked to type 1 diabetes mellitus.